P95 BV Acquires Assign DMB

P95 BV, a Belgium-based epidemiology and clinical solutions provider backed by Ampersand Capital Partners, has acquired Assign DMB, an Innsbruck, Austria-based clinical research organisation specializing in clinical data management and biostatistics. The deal expands P95's capabilities and capacity to run clinical and non-interventional studies—particularly in vaccines and infectious diseases—and broadens its presence in Europe and globally.